文献速递消化内镜消化道肿瘤与早癌

高容量与低容量分次剂量肠道准备方案在结肠镜检查中的疗效与耐受性:系统综述与Meta分析

Efficacy and Tolerability of High- vs Low-Volume Split-Dose Bowel Cleansing Regimens for Colonoscopy: A Systematic Review and Meta-analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-11-01

该系统综述与Meta分析纳入17项随机对照试验共7528例患者,比较低容量与高容量分次剂量肠道准备方案。结果显示两组肠道清洁充分率无显著差异(86.1% vs 87.4%;RR=1.00,95%CI 0.98-1.02),腺瘤检出率亦无显著差异(RR=0.96,95%CI 0.87-1.08)。低容量方案在依从性(RR=1.06,95%CI 1.02-1.10)、耐受性(RR=1.39,95%CI 1.12-1.74)和重复意愿(RR=1.41,95%CI 1.20-1.66)方面更优,总体证据质量中等。

要点

  • 低容量与高容量分次剂量方案肠道清洁充分率无显著差异(86.1% vs 87.4%;RR=1.00,95%CI 0.98-1.02)。
  • 低容量方案依从性更高(RR=1.06,95%CI 1.02-1.10)、耐受性更好(RR=1.39,95%CI 1.12-1.74)。
  • 低容量方案重复意愿更高(RR=1.41,95%CI 1.20-1.66),腺瘤检出率无显著差异(RR=0.96,95%CI 0.87-1.08)。

核心结论

  • 低容量分次剂量方案在肠道清洁效果上不劣于高容量分次剂量方案,且耐受性和依从性更优。

研究设计与样本

  • 系统综述与Meta分析,检索多个电子数据库至2019年1月31日,注册方案PROSPERO CRD42019128067,纳入17项随机对照试验共7528例患者。

主要发现

  • 低容量与高容量分次剂量方案肠道清洁充分率分别为86.1%和87.4%,无显著差异(RR=1.00;95%CI 0.98-1.02),异质性低(I2=17%)。
  • 4项随机对照试验的腺瘤检出率无显著差异(RR=0.96;95%CI 0.87-1.08)。
  • 低容量方案依从性或完成率更高(RR=1.06;95%CI 1.02-1.10),耐受性更好(RR=1.39;95%CI 1.12-1.74),重复意愿更高(RR=1.41;95%CI 1.20-1.66)。
  • 总体证据质量评估为中等。

关键数值与推荐

  • 主要疗效结局为肠道清洁充分率,次要疗效结局为腺瘤检出率。
  • 主要耐受性结局为依从性、耐受性和重复意愿。

临床怎么用

  • 在分次剂量给药前提下,可优先选择低容量肠道准备方案以提高患者依从性和耐受性,而不影响肠道清洁效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Efficacy of bowel preparation is an important determinant of outcomes of colonoscopy. It is not clear whether approved low-volume polyethylene glycol (PEG) and non-PEG regimens are as effective as high-volume PEG regimens when taken in a split dose. METHODS: In a systematic review of multiple electronic databases through January 31, 2019 with a registered protocol (PROSPERO: CRD42019128067), we identified randomized controlled trials that compared low- vs high-volume bowel cleansing regimens, administered in a split dose, for colonoscopy. The primary efficacy outcome was rate of adequate bowel cleansing, and the secondary efficacy outcome was adenoma detection rate. Primary tolerability outcomes were compliance, tolerability, and willingness to repeat. We calculated relative risk (RR) and 95% CI values and assessed heterogeneity among studies by using the I2 statistic. The overall quality of evidence was assessed using the GRADE framework. RESULTS: In an analysis of data from 17 randomized controlled trials, comprising 7528 patients, we found no significant differences in adequacy of bowel cleansing between the low- vs high-volume split-dose regimens (86.1% vs 87.4%; RR, 1.00; 95% CI, 0.98-1.02) and there was minimal heterogeneity (I2 = 17%). There was no significant difference in adenoma detection rate (RR, 0.96; 95% CI, 0.87-1.08) among 4 randomized controlled trials. Compared with high-volume, split-dose regimens, low-volume split-dose regimens had higher odds for compliance or completion (RR, 1.06; 95% CI, 1.02-1.10), tolerability (RR, 1.39; 95% CI, 1.12-1.74), and willingness to repeat bowel preparation (RR, 1.41; 95% CI, 1.20-1.66). The overall quality of evidence was moderate. CONCLUSIONS: Based on a systematic review of 17 randomized controlled trials, low-volume, split-dose regimens appear to be as effective as high-volume, split-dose regimens in bowel cleansing and are better tolerated, with superior compliance.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Spadaccini M, Frazzoni L, Vanella G, et al. Efficacy and Tolerability of High- vs Low-Volume Split-Dose Bowel Cleansing Regimens for Colonoscopy: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2019. PMID: 31683057. doi:10.1016/j.cgh.2019.10.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。